Stimulants (ADHD)

  • Pharmacy Author:
    Omudhome Ogbru, PharmD

    Dr. Ogbru received his Doctorate in Pharmacy from the University of the Pacific School of Pharmacy in 1995. He completed a Pharmacy Practice Residency at the University of Arizona/University Medical Center in 1996. He was a Professor of Pharmacy Practice and a Regional Clerkship Coordinator for the University of the Pacific School of Pharmacy from 1996-99.

  • Medical and Pharmacy Editor: Charles Patrick Davis, MD, PhD
    Charles Patrick Davis, MD, PhD

    Charles Patrick Davis, MD, PhD

    Dr. Charles "Pat" Davis, MD, PhD, is a board certified Emergency Medicine doctor who currently practices as a consultant and staff member for hospitals. He has a PhD in Microbiology (UT at Austin), and the MD (Univ. Texas Medical Branch, Galveston). He is a Clinical Professor (retired) in the Division of Emergency Medicine, UT Health Science Center at San Antonio, and has been the Chief of Emergency Medicine at UT Medical Branch and at UTHSCSA with over 250 publications.

What formulations of stimulants are available for treating ADHD?

Stimulants are available as immediate acting or long acting formulations and are available in the following formats:

  • Tablets (for example, Adderall, Concerta)
  • Capsules (for example, Adderall XR, Ritalin)
  • Chewable tablets (for example, Quillichew ER, Methylin)
  • Oral solution (for example, Methylin)
  • Transdermal Patch (for example, Daytrana)

Are stimulants safe to take during pregnancy or while breastfeeding?

  • Stimulants have not been adequately evaluated in pregnant women. Available evidence suggests that amphetamine type stimulants do not increase the rate of birth defects when used at recommended doses. However, decreased birth weight has been seen in infants whose mothers received dextroamphetamine for weight control.
  • There are no controlled studies of stimulants in women who are breastfeeding. There is every little information on the effect of methylphenidate on the developing fetus. Stimulants should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

REFERENCES:

FDA approved prescribing information for ADHD medications.

Humphreys C, Garcia-Bournissen F, Ito S, Koren G. Exposure to attention deficit hyperactivity disorder medications during pregnancy. Canadian Family Physician. 2007;53(7):1153-1155.

Medically Reviewed by a Doctor on 11/16/2016

Quick GuideADHD/ADD in Adults: Symptoms & Treatments in Pictures

ADHD/ADD in Adults: Symptoms & Treatments in Pictures
FDA Logo

Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

RxList Logo

Need help identifying pills and medications?

Use the pill identifier tool on RxList.

Subscribe to MedicineNet's Newsletters

Get the latest health and medical information delivered direct to your inbox!

By clicking Submit, I agree to the MedicineNet's Terms & Conditions & Privacy Policy and understand that I may opt out of MedicineNet's subscriptions at any time.

Health Solutions From Our Sponsors